MarketPeel
Insider Trading Intelligence
Pricing
…
MB

Matthew Bowen

GLUE
PRINCIPAL ACCOUNTING OFFICER · MONTE ROSA THERAPEUTICS, INC. · CIK 0002115025
FILING MIX · LIFETIME100%/0%
BUYS
2
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Apr 2026
HOLDINGS NOW
25,904
AVG SELL PX
—
TRADE KIND
SHOWING 2 / 2
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Matthew Bowen. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
GLUE · 25,904 shares · as of Apr 6, 2026
06,47612,95219,42825,904SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2026
FLOW · 2 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
19,500——19,500Apr 6, 2026Apr 7, 2026 ↗
GLUE
MONTE ROSA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,300——25,904Apr 6, 2026Apr 7, 2026 ↗
Other insiders · GLUE
Loading peer insiders…
About this filer
CIK 0002115025
ROLE
Principal Accounting Officer
PRIMARY
GLUE
COMPANIES
1
ACTIVE SINCE
Apr 2026
MARKETPEEL · /INSIDER/0002115025DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback